Control of hepatitis C in Iran: Vision and Missions

Hepatitis Monthly

Volumn 7, Issue 2, 2007, Pages 57-58

  Alavian, Seyed Moayed ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PEGINTERFERON ALPHA;

BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; COMPUTER NETWORK; DRUG ABUSE; EDITORIAL; HEMODIALYSIS; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; THALASSEMIA;

EID: 84990301685     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton) 2003; 8: 256-60.
2. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol 2005; 11: 4085-9.
3. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17: 1092-7.
4. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med 2005; 8: 84-90.
5. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res 2007; 37: 101-3.
6. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 2006; 5: 4.
7. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol 2006; 78: 569-73.
8. Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with “illegal social behaviour”. Sex Transm Infect 2005; 81: 185.
9. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 2003; 18: 836-40.
10. Zali MR, Aghazadeh R, Nowroozi A. Anti-HCV antibody among Iranian IV drug users: is it a serious problem? Arch Iran Med 2001; 4: 115-9.
11. Alavian SM. Triangular clinics: The way of the future. Hep Mon 2005; 5: 51-2.
12. Alavian SM, Ardeshiri A, Hajarizadeh B. Seroprevalence of anti-HCVAb among Iranian hemophilia patients. Transfusion Today 2001; 49: 4-5.
13. Alavian SM. Prevalence of HCV, HBV and HIV infection among hemophiliacs patients. HakimResearch Journal 2003; 6: 45-51.